CardioLogs ECG Analysis Platform vs Rapid RV/LV
AI Verdict
Choose CardioLogs ECG Analysis Platform if…
Choose CardioLogs ECG Analysis Platform if your primary need is a comprehensive, AI-driven solution for detecting a wide range of arrhythmias from diverse ECG sources, including Holter monitors and smartwatches. This cloud-based platform is ideal for practices seeking rapid, accurate analysis and customizable reports accessible from anywhere, streamlining arrhythmia diagnosis workflows.
View CardioLogs ECG Analysis Platform →Choose Rapid RV/LV if…
Choose Rapid RV/LV if your clinical focus is the rapid and objective assessment of pulmonary embolism severity directly from CTPA scans. This AI tool is best suited for emergency departments and radiology practices requiring automated, consistent measurement of right and left ventricle ratios to quickly inform treatment decisions for suspected PE cases.
View Rapid RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CardioLogs ECG Analysis Platform | Rapid RV/LV |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing information. |
| Deployment | Cloud-based | On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardioLogs ECG Analysis PlatformTool A, CardioLogs ECG Analysis Platform, is cloud-based (SaaS) and offers multi-device compatibility, including smartwatches, which generally translates to easier access and a more flexible user experience. Tool B, Rapid RV/LV, primarily uses on-premises or hybrid deployment, which can involve more complex setup and maintenance for end-users compared to a pure SaaS model.
Clinical Value
TieBoth tools offer significant clinical value by providing rapid, AI-powered analysis for critical conditions and are FDA-cleared. Tool A aids in arrhythmia detection and diagnosis from ECG data, while Tool B assesses pulmonary embolism severity from CTPA scans. They address different, yet equally critical, clinical problems.
Pricing & Value
CardioLogs ECG Analysis PlatformTool A, CardioLogs ECG Analysis Platform, offers a more transparent pricing model with a 'Pay per ECG regardless of the number of users' structure, allowing for clearer cost estimation. Tool B, Rapid RV/LV, requires contacting the vendor for pricing details, which provides less upfront transparency for potential customers.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. Tool A's cloud-based SaaS deployment with ISO/IEC 27001 certification and EHR integration offers scalability, while Tool B's on-premises/hybrid option with integration into a broader platform caters to different enterprise infrastructure preferences and data control needs.
Innovation
CardioLogs ECG Analysis PlatformTool A, CardioLogs ECG Analysis Platform, demonstrates broader innovation by applying deep neural networks to a wide range of ECG devices, including smartwatches, and leveraging a cloud-native approach to reinvent cardiology diagnostics. Tool B, Rapid RV/LV, offers focused innovation in automating RV/LV ratio measurement from CTPA for PE severity, which is impactful but more specialized.
Support & Docs
Rapid RV/LVRapidAI (Tool B) provides clear and comprehensive customer support information, including 24/7/365 availability via email and phone with multiple international numbers, and a dedicated help center. While Philips (Tool A) offers support for Cardiologs, the information is less consolidated and directs users to contact support via the platform's 'Help' menu, or through general Philips healthcare support channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CardioLogs ECG Analysis Platform | Rapid RV/LV |
|---|---|---|
| Name | CardioLogs ECG Analysis Platform | Rapid RV/LV |
| Company | Cardiologs Technologies (now part of Philips) | RapidAI (formerly iSchemaView) |
| Description | The Cardiologs ECG Analysis Platform, now a Philips solution, uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. | Rapid RV/LV by RapidAI is an FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. |
| Primary Data Analyzed | ECG data from various cardiac monitoring devices | CTPA scans |
| Key Functionality | AI-Powered ECG Analysis, Automated Arrhythmia Detection | Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Rapid RV/LV.